Biohaven Ltd (BHVN)
45.57
+0.38
(+0.84%)
USD |
NYSE |
Nov 22, 15:15
Biohaven Total Assets (Quarterly): 510.52M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 510.52M |
| June 30, 2024 | 582.64M |
| March 31, 2024 | 418.53M |
| December 31, 2023 | 513.21M |
| September 30, 2023 | 382.74M |
| June 30, 2023 | 506.74M |
| Date | Value |
|---|---|
| March 31, 2023 | 618.52M |
| December 31, 2022 | 661.78M |
| September 30, 2022 | 135.65M |
| June 30, 2022 | 332.81M |
| December 31, 2021 | 142.06M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
135.65M
Minimum
Sep 2022
661.78M
Maximum
Dec 2022
436.84M
Average
506.74M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Scholar Rock Holding Corp | 179.13M |
| Veru Inc | 64.63M |
| Regeneron Pharmaceuticals Inc | 37.44B |
| Vanda Pharmaceuticals Inc | 645.12M |
| Oramed Pharmaceuticals Inc | 165.08M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 194.52M |
| Shareholders Equity (Quarterly) | 316.01M |